|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 26669 |
FusionGeneSummary for PEPD_CEBPG |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PEPD_CEBPG | Fusion gene ID: 26669 | Hgene | Tgene | Gene symbol | PEPD | CEBPG | Gene ID | 5184 | 1054 |
| Gene name | peptidase D | CCAAT enhancer binding protein gamma | |
| Synonyms | PROLIDASE | GPE1BP|IG/EBP-1 | |
| Cytomap | 19q13.11 | 19q13.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | xaa-Pro dipeptidaseX-Pro dipeptidaseaminoacyl-L-proline hydrolaseimidodipeptidaseproline dipeptidasetesticular tissue protein Li 138 | CCAAT/enhancer-binding protein gammaCCAAT/enhancer binding protein (C/EBP), gammac/EBP gamma | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | P12955 | P53567 | |
| Ensembl transtripts involved in fusion gene | ENST00000244137, ENST00000397032, ENST00000436370, ENST00000591968, | ENST00000284000, ENST00000585933, | |
| Fusion gene scores | * DoF score | 6 X 4 X 6=144 | 4 X 1 X 3=12 |
| # samples | 6 | 3 | |
| ** MAII score | log2(6/144*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: PEPD [Title/Abstract] AND CEBPG [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CEBPG | GO:0006357 | regulation of transcription by RNA polymerase II | 16255782 |
| Tgene | CEBPG | GO:0045944 | positive regulation of transcription by RNA polymerase II | 15833715 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | UCEC | TCGA-D1-A3JP-01A | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000244137 | ENST00000284000 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| 5CDS-5UTR | ENST00000244137 | ENST00000585933 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| 5CDS-5UTR | ENST00000397032 | ENST00000284000 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| 5CDS-5UTR | ENST00000397032 | ENST00000585933 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| 5CDS-5UTR | ENST00000436370 | ENST00000284000 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| 5CDS-5UTR | ENST00000436370 | ENST00000585933 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| intron-5UTR | ENST00000591968 | ENST00000284000 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
| intron-5UTR | ENST00000591968 | ENST00000585933 | PEPD | chr19 | 33902578 | - | CEBPG | chr19 | 33870050 | + |
Top |
FusionProtFeatures for PEPD_CEBPG |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PEPD | CEBPG |
| Transcription factor that binds to the promoter and theenhancer regions of target genes. Binds to the enhancer elementPRE-I (positive regulatory element-I) of the IL-4 gene(PubMed:7665092). Binds to the promoter and the enhancer of theimmunoglobulin heavy chain. Binds to GPE1, a cis-acting element inthe G-CSF gene promoter. {ECO:0000250|UniProtKB:P26801,ECO:0000250|UniProtKB:P53568, ECO:0000269|PubMed:7665092}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PEPD_CEBPG |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PEPD_CEBPG |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PEPD | TERF1, CUL2, ATXN1, SPP1, ASS1, BCCIP, CAPN1, CASP7, DLD, DPP3, EIF5A, FTO, GBP2, GDA, GINS2, GLS, GNS, LDHAL6B, MVD, NDRG1, CNDP2, EIF4E, EIF6, GSR, KYNU, NAMPT, NHLRC2, CTSA, RPS6KA1, USP7, MOV10, NXF1, GOT1, HSPE1, LDHA, LDHB, RPIA, SOD2, PSMG4, TANGO2 | CEBPG | MLLT6, POLR2M, DDIT3, CEBPB, CDK2, ELAVL1, CEBPE, BATF3, BATF2, BATF, ATF3, DBP, CEBPA, PLAU, ATF4, FOSL1, FOS, JUN, ATF2, CREB3, CEBPG, KLF5 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PEPD_CEBPG |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PEPD_CEBPG |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PEPD | C0268532 | Deficiency of prolidase | 5 | CTD_human;ORPHANET;UNIPROT |
| Hgene | PEPD | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| Hgene | PEPD | C0019209 | Hepatomegaly | 1 | CTD_human;HPO |
| Hgene | PEPD | C0035242 | Respiratory Tract Diseases | 1 | CTD_human |
| Hgene | PEPD | C0037299 | Skin Ulcer | 1 | CTD_human;HPO |
| Hgene | PEPD | C0038002 | Splenomegaly | 1 | CTD_human;HPO |
| Hgene | PEPD | C0700359 | Organophosphate poisoning | 1 | CTD_human |
| Hgene | PEPD | C3714514 | Infection | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|